Therapeutic efficacy and safety of S-1-based combination therapy compare with S-1 monotherapy following gemcitabine failure in pancreatic cancer: a meta-analysis.

Sinan Lu,Yuan Zhang,Xiaohu Zhou,Dongkai Zhou,Qifan Yang,Bingjie Ju,Xinyi Zhao,Zhenhua Hu,Haiyang Xie,Lin Zhou,Shusen Zheng,Weilin Wang

Therapeutic efficacy and safety of S-1-based combination therapy compare with S-1 monotherapy following gemcitabine failure in pancreatic cancer: a meta-analysis.

2016

Sinan Lu
Yuan Zhang
Xiaohu Zhou
Dongkai Zhou
Qifan Yang
Bingjie Ju
Xinyi Zhao
Zhenhua Hu
Haiyang Xie
Lin Zhou
Shusen Zheng
Weilin Wang

Therapeutic efficacy and safety of S-1-based combination therapy compare with S-1 monotherapy following gemcitabine failure in pancreatic cancer: a meta-analysis

Keywords:

Meta-analysis
Oncology
Tegafur
Pancreatic cancer
Gemcitabine
Combination therapy
Deoxycytidine
Internal medicine
Oxonic Acid
Medicine
Confidence interval
Relative risk
Randomized controlled trial
Hazard ratio
Adverse effect

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations